Spinnaker Trust Invests $201,000 in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Spinnaker Trust purchased a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 385 shares of the medical equipment provider’s stock, valued at approximately $201,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of ISRG. Massachusetts Financial Services Co. MA purchased a new stake in shares of Intuitive Surgical in the third quarter worth about $558,807,000. International Assets Investment Management LLC lifted its holdings in shares of Intuitive Surgical by 49,383.6% in the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock worth $535,788,000 after buying an additional 1,088,415 shares in the last quarter. FMR LLC lifted its holdings in shares of Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after buying an additional 838,793 shares in the last quarter. Wilmington Savings Fund Society FSB lifted its holdings in shares of Intuitive Surgical by 15,322.2% in the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after buying an additional 552,058 shares in the last quarter. Finally, Strategic Financial Concepts LLC raised its stake in Intuitive Surgical by 50,740.8% in the fourth quarter. Strategic Financial Concepts LLC now owns 312,671 shares of the medical equipment provider’s stock valued at $163,202,000 after purchasing an additional 312,056 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, EVP Myriam Curet sold 408 shares of the company’s stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the transaction, the executive vice president now owns 353 shares in the company, valued at $208,181.75. The trade was a 53.61 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Jamie Samath sold 108 shares of the business’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. This trade represents a 1.22 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 6,348 shares of company stock worth $3,587,582 in the last quarter. Corporate insiders own 0.90% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. Stifel Nicolaus lifted their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. Evercore ISI lifted their target price on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Jefferies Financial Group lifted their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their target price for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. Finally, Citigroup lifted their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Trading Up 0.7 %

Shares of ISRG stock opened at $595.55 on Friday. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The stock has a market cap of $212.12 billion, a PE ratio of 92.91, a price-to-earnings-growth ratio of 5.67 and a beta of 1.39. The company’s fifty day moving average price is $559.48 and its 200-day moving average price is $519.06.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.